Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.
Peptide A
Cognitive
Full-length adrenocorticotropic hormone — endocrine research peptide, melanocortin agonist.
Peptide B
Cognitive
Neuroprotective ACTH analog with nootropic and neurotrophic properties.
Typical vial
5 mg
Typical dose
250 (diagnostic) mcg
Half-life
~10-15 minutes (plasma)
FDA status
Cosyntropin (ACTH 1-24) FDA approved as Cortrosyn. Repositor…
Typical vial
5 mg
Typical dose
200-600 mcg
Half-life
~2-3 minutes (very rapid degradation; biological effects last hours due to downstream gene expression changes)
FDA status
Not FDA approved for human use. Approved in Russia for strok…
ACTH 1-39 (Corticotropin) effects
Semax effects
ACTH 1-39 (Corticotropin) side effects
Semax side effects
ACTH 1-39 (Corticotropin) dosing ranges
Adrenal stimulation test (clinical)
250 mcg · Single IV or IM dose · Diagnostic, one-time
Endocrine research
Variable · Per study protocol · Per study protocol
Semax dosing ranges
Cognitive enhancement
200-600 mcg · Once or twice daily (intranasal) · 10-20 days per course
Neuroprotection / stroke recovery
600-1200 mcg · Two to three times daily (intranasal) · 10-14 days
ACTH 1-39 (Corticotropin): Full-length adrenocorticotropic hormone — endocrine research peptide, melanocortin agonist. Typical dose 250 (diagnostic) mcg. Semax: Neuroprotective ACTH analog with nootropic and neurotrophic properties. Typical dose 200-600 mcg. Both fall under the Cognitive category.
Stacking ACTH 1-39 (Corticotropin) with Semax is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.
ACTH 1-39 (Corticotropin) is typically dosed: Single IV or IM dose for Adrenal stimulation test (clinical); Per study protocol for Endocrine research. Semax is typically dosed: Once or twice daily (intranasal) for Cognitive enhancement; Two to three times daily (intranasal) for Neuroprotection / stroke recovery.
ACTH 1-39 (Corticotropin): Cosyntropin (ACTH 1-24) FDA approved as Cortrosyn. Repository ACTH (porcine, full-length) FDA approved as Acthar Gel for infantile spasms, MS exacerbations, and other indications. Semax: Not FDA approved for human use. Approved in Russia for stroke recovery, cognitive impairment, and optic nerve disease.
Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.
Get Started Free